Shukla M, Chandley P, Rohatgi S
Vaccines (Basel). 2021; 9(10).
PMID: 34696267
PMC: 8540628.
DOI: 10.3390/vaccines9101159.
Riciluca K, Oliveira U, Mendonca R, Bozelli Junior J, Schreier S, da Silva Junior P
FEBS Open Bio. 2021; 11(9):2541-2559.
PMID: 34254458
PMC: 8409319.
DOI: 10.1002/2211-5463.13253.
Espinosa-Tamez P, Lajous M, Cantu-Brito C, Lopez-Ridaura R, Monge A, Yunes E
PLoS One. 2021; 16(1):e0246047.
PMID: 33497395
PMC: 7837493.
DOI: 10.1371/journal.pone.0246047.
Rodriguez A, Vaneechoutte M
BMC Microbiol. 2019; 19(1):94.
PMID: 31088364
PMC: 6515685.
DOI: 10.1186/s12866-019-1473-z.
Huai Y, Dong S, Zhu Y, Li X, Cao B, Gao X
Adv Healthc Mater. 2016; 5(7):786-94.
PMID: 26890982
PMC: 4828319.
DOI: 10.1002/adhm.201500930.
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.
Pericolini E, Gabrielli E, Amacker M, Kasper L, Roselletti E, Luciano E
mBio. 2015; 6(3):e00724.
PMID: 26037125
PMC: 4453014.
DOI: 10.1128/mBio.00724-15.
Fungal vaccines and immunotherapeutics.
Santos E, Levitz S
Cold Spring Harb Perspect Med. 2014; 4(11):a019711.
PMID: 25368016
PMC: 4208708.
DOI: 10.1101/cshperspect.a019711.
Candida infections and their prevention.
Kabir M, Ahmad Z
ISRN Prev Med. 2014; 2013:763628.
PMID: 24977092
PMC: 4062852.
DOI: 10.5402/2013/763628.
IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis.
De Luca A, Carvalho A, Cunha C, Iannitti R, Pitzurra L, Giovannini G
PLoS Pathog. 2013; 9(7):e1003486.
PMID: 23853597
PMC: 3708875.
DOI: 10.1371/journal.ppat.1003486.
Genetic basis for recurrent vulvo-vaginal candidiasis.
Jaeger M, Plantinga T, Joosten L, Kullberg B, Netea M
Curr Infect Dis Rep. 2013; 15(2):136-42.
PMID: 23354953
DOI: 10.1007/s11908-013-0319-3.
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.
Vecchiarelli A, Pericolini E, Gabrielli E, Pietrella D
Front Microbiol. 2012; 3:294.
PMID: 22905033
PMC: 3417234.
DOI: 10.3389/fmicb.2012.00294.
Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.
Rossi D, Munoz J, Carvalho D, Belmonte R, Faintuch B, Borelli P
BMC Microbiol. 2012; 12:28.
PMID: 22394555
PMC: 3361493.
DOI: 10.1186/1471-2180-12-28.
Th17 cells and IL-17 in protective immunity to vaginal candidiasis.
Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F
PLoS One. 2011; 6(7):e22770.
PMID: 21818387
PMC: 3144947.
DOI: 10.1371/journal.pone.0022770.
Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection.
Pietrella D, Angiolella L, Vavala E, Rachini A, Mondello F, Ragno R
BMC Complement Altern Med. 2011; 11:18.
PMID: 21356078
PMC: 3056850.
DOI: 10.1186/1472-6882-11-18.
The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.
Donders G, Bellen G, Ausma J, Verguts L, Vaneldere J, Hinoul P
Eur J Clin Microbiol Infect Dis. 2010; 30(1):59-63.
PMID: 20878199
DOI: 10.1007/s10096-010-1052-6.
Host responses to Candida albicans: Th17 cells and mucosal candidiasis.
Conti H, Gaffen S
Microbes Infect. 2010; 12(7):518-27.
PMID: 20381638
PMC: 2892252.
DOI: 10.1016/j.micinf.2010.03.013.
Candida infections of the genitourinary tract.
Achkar J, Fries B
Clin Microbiol Rev. 2010; 23(2):253-73.
PMID: 20375352
PMC: 2863365.
DOI: 10.1128/CMR.00076-09.
Local treatment of vulvovaginal candidosis : general and practical considerations.
das Neves J, Pinto E, Teixeira B, Dias G, Rocha P, Cunha T
Drugs. 2008; 68(13):1787-802.
PMID: 18729533
DOI: 10.2165/00003495-200868130-00002.
C. albicans colonization of human mucosal surfaces.
Southern P, Horbul J, Maher D, Davis D
PLoS One. 2008; 3(4):e2067.
PMID: 18446191
PMC: 2297513.
DOI: 10.1371/journal.pone.0002067.
Animal models of mucosal Candida infection.
Naglik J, Fidel Jr P, Odds F
FEMS Microbiol Lett. 2008; 283(2):129-39.
PMID: 18422625
PMC: 3244615.
DOI: 10.1111/j.1574-6968.2008.01160.x.